{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:40:17Z","timestamp":1756374017337,"version":"3.44.0"},"reference-count":17,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2022,7,12]]},"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:p>A man in his 70s presented with impaired consciousness due to hyperammonaemia while investigating multiple tumours in his brain, chest, spine and right adrenal gland. He did not have any disorders causing hyperammonaemia, such as liver dysfunction, urea-producing bacterial infection or any medications interfering with ammonium metabolism. Blood and urine tests in addition to tumour biopsy specimens confirmed immunoglobulin D lambda multiple myeloma. His general status responded to chemotherapy using bortezomib, dexamethasone and daratumumab, and he subsequently regained full consciousness and a normalised serum ammonia level. He, unfortunately, died of refractory multiple myeloma with hyperammonaemia. The autopsy specimen revealed lambda light-chain deposits in the distal tubule epithelium with cast precipitation and intact liver cells. Urine osmolality gap analysis suggested possibly reduced urinary ammonium excretion, but further investigation is necessary to elucidate the significance of pathological renal characteristics in multiple myeloma with hyperammonaemia.<\/jats:p>","DOI":"10.1136\/bcr-2021-248245","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T11:15:38Z","timestamp":1658315738000},"page":"e248245","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["IgD lambda multiple myeloma causing hyperammonaemia with possibly reduced ammonium excretion"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5283-1592","authenticated-orcid":false,"given":"Naohi","family":"Isse","sequence":"first","affiliation":[{"name":"General Medicine, Okayama Kyoritsu General Hospital, Okayama, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Nakahara","sequence":"additional","affiliation":[{"name":"Toho University, Ota-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryutaro","family":"Sasai","sequence":"additional","affiliation":[{"name":"Ako City Hospital, Ako, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,7,20]]},"reference":[{"key":"2025082802084705000_15.7.e248245.1","unstructured":"Laubach JP . Multiple myeloma: Clinical features, laboratory manifestations, and diagnosis. In: UpToDate, Post TW, eds. UpToDate, Waltham, MA."},{"key":"2025082802084705000_15.7.e248245.2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401077"},{"key":"2025082802084705000_15.7.e248245.3","unstructured":"Fenves AZ , Schwartz JC , Rees L . Intermittent dialysis and continuous modalities for patients with hyperammonemia. In: UpToDate, Post TW, eds. UpToDate, Waltham, MA."},{"key":"2025082802084705000_15.7.e248245.4","first-page":"557","article-title":"Hyperammonemic encephalopathy in multiple myeloma","volume":"9","author":"Furer","year":"2007","journal-title":"Isr Med Assoc J"},{"key":"2025082802084705000_15.7.e248245.5","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2008.n.054"},{"key":"2025082802084705000_15.7.e248245.6","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-010-1369-2"},{"key":"2025082802084705000_15.7.e248245.7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00467-017-3829-7","article-title":"Hyperammonemia associated with distal renal tubular acidosis or urinary tract infection: a systematic review","volume":"33","author":"Clericetti","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"2025082802084705000_15.7.e248245.8","article-title":"Presentation patterns, diagnostic markers, management strategies, and outcomes of IgD multiple myeloma: a systematic review of literature","volume":"11","author":"Selene","year":"2019","journal-title":"Cureus"},{"key":"2025082802084705000_15.7.e248245.9","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.40.931"},{"key":"2025082802084705000_15.7.e248245.10","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2008.n.054"},{"key":"2025082802084705000_15.7.e248245.11","article-title":"Hyperammonemic encephalopathy: a unique presentation of multiple myeloma","volume":"13","author":"Douedi","year":"2021","journal-title":"Cureus"},{"key":"2025082802084705000_15.7.e248245.12","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.117176"},{"key":"2025082802084705000_15.7.e248245.13","doi-asserted-by":"crossref","DOI":"10.1186\/s12878-016-0047-7","article-title":"A case of multiple myeloma presenting as a distal renal tubular acidosis with extensive bilateral nephrolithiasis","volume":"16","author":"Fonseka","year":"2016","journal-title":"BMC Hematol"},{"key":"2025082802084705000_15.7.e248245.14","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.2169\/internalmedicine.1323-18","article-title":"Lambda light chain non-crystalline proximal tubulopathy with IgD lambda myeloma","volume":"57","author":"Kishi","year":"2018","journal-title":"Intern Med"},{"key":"2025082802084705000_15.7.e248245.15","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02560316"},{"key":"2025082802084705000_15.7.e248245.16","unstructured":"Emmett M , Palmer BF . Urine anion and osmolal gaps in metabolic acidosis. In: UpToDate, Post TW, eds. UpToDate, Waltham, MA."},{"key":"2025082802084705000_15.7.e248245.17","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/nep.13937","article-title":"Assessing urine ammonium concentration by urine osmolal gap in chronic kidney disease","volume":"26","author":"Fujimaru","year":"2021","journal-title":"Nephrology"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-248245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:08:55Z","timestamp":1756372135000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-248245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":17,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7,20]]},"published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10.1136\/bcr-2021-248245"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-248245","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}